Showing results (31-40 of 1,066) with videos related to
Sort By:
Pageof 107
Therapeutic Drug Monitoring|September 1, 1990
Nonlinear kinetics of imipramine in low and medium plasma level rangesS H Sindrup, K Brøsen, L F GramTherapeutic Drug Monitoring|March 1, 1991
Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine, and mephenytoinK Brøsen, L F Gram, P Kragh-SørensenJournal of Affective Disorders|January 1, 1993
Outpatient utilization of antidepressants: a prescription database analysisJ U Rosholm, J Hallas, L F GramEuropean Journal of Clinical Pharmacology|September 11, 2001
Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish populationJ Larsen, M Andersen, J Kragstrup, et al.Journal of Hypertension|May 1, 1989
Plasma noradrenaline response to a multistage exercise test in young men at increased risk of developing essential hypertensionJ R Nielsen, L F Gram, P K PedersenPsychopharmacology|January 1, 1984
Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressantsP Bech, P Allerup, N Reisby, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liverS V Otton, R U Brinn, L F GramBritish Journal of Clinical Pharmacology|May 1, 1989
Mephenytoin and sparteine oxidation: genetic polymorphisms in DenmarkA Drøhse, L Bathum, K Brøsen, et al.Psychopharmacology|January 1, 1985
Mianserin protein binding in serum and plasma from healthy subjects and patients with depression and rheumatoid arthritisC B Kristensen, L F Gram, P Kragh-SørensenJAMA|April 6, 1984
Imipramine treatment of painful diabetic neuropathyB Kvinesdal, J Molin, A Frøland, et al.Pageof 107